FDA Warning Letter — Novacyl Wuxi Pharmaceutical Co., Ltd.

Case 420362 — FEI 3004117396

The FDA took a Warning Letter action against Novacyl Wuxi Pharmaceutical Co., Ltd. on December 19, 2014 (Wuxi, China). The action was issued by CDER and concerns drugs products. This facility has 3 recent FDA inspections on record.

Action Details

Facility
Novacyl Wuxi Pharmaceutical Co., Ltd.
Date
December 19, 2014
Fiscal Year
2015
Product Type
Drugs
Center
CDER
Location
Wuxi (China)